IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 414.52 USD -0.66% Market Closed
Market Cap: 34.1B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
IDEXX Laboratories Inc

Current Assets 1.4B
Cash & Short-Term Investments 308.6m
Receivables 511.3m
Other Current Assets 613.9m
Non-Current Assets 1.9B
PP&E 717.7m
Other Non-Current Assets 1.2B
Current Liabilities 1B
Accounts Payable 110.6m
Accrued Liabilities 511m
Short-Term Debt 250m
Other Current Liabilities 137.6m
Non-Current Liabilities 723.5m
Long-Term Debt 524.8m
Other Non-Current Liabilities 198.7m

Balance Sheet
IDEXX Laboratories Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
323
129
155
188
124
90
384
145
113
454
Cash Equivalents
323
129
155
188
124
90
384
145
113
454
Short-Term Investments
0
214
237
284
0
0
0
0
0
0
Total Receivables
181
200
232
270
273
308
375
426
491
530
Accounts Receivables
152
188
205
235
259
287
355
406
443
513
Other Receivables
29
12
28
36
14
21
19
20
48
17
Inventory
160
189
158
164
173
195
210
269
368
380
Other Current Assets
95
90
64
66
84
87
94
117
130
132
Total Current Assets
759
822
846
972
654
680
1 063
956
1 102
1 495
PP&E Net
304
333
357
379
437
615
646
693
768
818
PP&E Gross
304
333
357
379
437
615
646
693
768
818
Accumulated Depreciation
300
346
385
433
469
519
587
648
706
785
Intangible Assets
65
56
46
44
42
59
53
99
98
85
Goodwill
185
179
178
200
215
240
243
359
362
366
Note Receivable
0
0
0
0
31
81
98
124
150
168
Long-Term Investments
11
12
11
10
11
14
12
19
56
56
Other Long-Term Assets
61
73
92
109
147
145
180
188
213
272
Other Assets
185
179
178
200
215
240
243
359
362
366
Total Assets
1 384
N/A
1 475
+7%
1 531
+4%
1 713
+12%
1 537
-10%
1 833
+19%
2 295
+25%
2 437
+6%
2 747
+13%
3 260
+19%
Liabilities
Accounts Payable
45
53
60
67
70
72
75
116
110
111
Accrued Liabilities
165
185
211
224
234
289
373
416
385
392
Short-Term Debt
549
573
611
655
399
289
0
74
579
250
Current Portion of Long-Term Debt
0
0
0
0
0
0
50
75
75
75
Other Current Liabilities
63
46
52
59
69
76
85
83
87
124
Total Current Liabilities
821
857
935
1 005
770
725
583
764
1 236
952
Long-Term Debt
350
500
499
500
500
600
859
775
694
623
Deferred Income Tax
42
49
39
25
29
33
12
9
8
7
Minority Interest
0
0
0
0
0
0
1
0
0
0
Other Liabilities
54
153
166
238
247
297
209
200
200
194
Total Liabilities
1 267
N/A
1 559
+23%
1 639
+5%
1 768
+8%
1 547
-12%
1 655
+7%
1 663
+0%
1 747
+5%
2 138
+22%
1 775
-17%
Equity
Common Stock
15
16
16
16
15
15
15
16
16
16
Retained Earnings
1 675
318
540
804
1 168
1 596
2 176
2 920
3 600
4 445
Additional Paid In Capital
888
941
1 012
1 074
1 138
1 214
1 295
1 377
1 463
1 570
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
2 453
1 316
1 633
1 912
2 289
2 601
2 800
3 571
4 392
4 475
Other Equity
8
42
43
36
42
46
53
53
78
71
Total Equity
118
N/A
84
N/A
108
-29%
54
+50%
10
+82%
178
N/A
632
+256%
690
+9%
609
-12%
1 485
+144%
Total Liabilities & Equity
1 384
N/A
1 475
+7%
1 531
+4%
1 713
+12%
1 537
-10%
1 833
+19%
2 295
+25%
2 437
+6%
2 747
+13%
3 260
+19%
Shares Outstanding
Common Shares Outstanding
95
90
88
87
86
86
85
85
83
83

See Also

Discover More